These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 15078182)

  • 1. Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection.
    Morris KV; Rossi JJ
    Curr HIV Res; 2004 Apr; 2(2):185-91. PubMed ID: 15078182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral vectors for gene therapy of HIV-1 infection.
    Mautino MR
    Curr Gene Ther; 2002 Feb; 2(1):23-43. PubMed ID: 12108972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic-based therapies to select nonpathogenic variants of HIV-1.
    Morris KV
    Per Med; 2007 Aug; 4(3):261-269. PubMed ID: 29788674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
    Chang LJ; Liu X; He J
    Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral-mediated delivery of siRNAs for antiviral therapy.
    Morris KV; Rossi JJ
    Gene Ther; 2006 Mar; 13(6):553-8. PubMed ID: 16397511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy of HIV-1 infection using lentiviral vectors expressing anti-HIV-1 genes.
    Mautino MR; Morgan RA
    AIDS Patient Care STDS; 2002 Jan; 16(1):11-26. PubMed ID: 11839215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.
    Li MJ; Bauer G; Michienzi A; Yee JK; Lee NS; Kim J; Li S; Castanotto D; Zaia J; Rossi JJ
    Mol Ther; 2003 Aug; 8(2):196-206. PubMed ID: 12907142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy.
    Chung J; Zhang J; Li H; Ouellet DL; DiGiusto DL; Rossi JJ
    Hum Gene Ther; 2012 Nov; 23(11):1200-8. PubMed ID: 22834872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection.
    Morris KV; Rossi JJ
    Hum Gene Ther; 2006 May; 17(5):479-86. PubMed ID: 16716105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
    Nash KL; Alexander GJ; Lever AM
    J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of infectious human immunodeficiency virus type 1 virions via lentiviral vector encoded short antisense RNAs.
    Gu S; Ji J; Kim JD; Yee JK; Rossi JJ
    Oligonucleotides; 2006; 16(4):287-95. PubMed ID: 17155905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of an anti-HIV-1 combination gene therapy strategy using the antisense RNA and multimeric hammerhead ribozymes.
    Ramezani A; Ma XZ; Ameli M; Arora A; Joshi S
    Front Biosci; 2006 Sep; 11():2940-8. PubMed ID: 16720366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes.
    Zhou C; Bahner IC; Larson GP; Zaia JA; Rossi JJ; Kohn EB
    Gene; 1994 Nov; 149(1):33-9. PubMed ID: 7958986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS.
    Akkina R; Banerjea A; Bai J; Anderson J; Li MJ; Rossi J
    Anticancer Res; 2003; 23(3A):1997-2005. PubMed ID: 12894572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
    Ding SF; Lombardi R; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNA.
    Mautino MR; Morgan RA
    Hum Gene Ther; 2002 Jun; 13(9):1027-37. PubMed ID: 12067436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of HIV-1 in vitro by combination of vpr and tat specific short hairpin RNA via lentiviral vectors].
    Hao YZ; Teng ZP; Yang YS; Sun XN; Ma J; Jin XH; Zeng Y
    Bing Du Xue Bao; 2013 Mar; 29(2):126-31. PubMed ID: 23757841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication.
    Bahner I; Sumiyoshi T; Kagoda M; Swartout R; Peterson D; Pepper K; Dorey F; Reiser J; Kohn DB
    Mol Ther; 2007 Jan; 15(1):76-85. PubMed ID: 17164778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human immunodeficiency virus (HIV)-2 vector mobilization by HIV-1.
    Morris KV; Looney DJ
    Hum Gene Ther; 2005 Dec; 16(12):1463-72. PubMed ID: 16390277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages.
    Banerjea A; Li MJ; Bauer G; Remling L; Lee NS; Rossi J; Akkina R
    Mol Ther; 2003 Jul; 8(1):62-71. PubMed ID: 12842429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.